CONMED Corp — Director's Dealing 2020

Nov 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-11-13

Reporting Person: Peters Stanley W III (VP GM Advanced Surgery)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-13	Common Stock	M	446	$39.87	Acquired	509	Direct
2020-11-13	Common Stock	S	446	$94.5204	Disposed	63	Direct
2020-11-13	Common Stock	M	9000	$39.87	Acquired	9063	Direct
2020-11-13	Common Stock	S	9000	$94.3037	Disposed	63	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-13	Options To Purchase Common Stock	$39.87	M	446	Disposed	2026-03-01	Common Stock (446)	Direct
2020-11-13	Options To Purchase Common Stock	$39.87	M	9000	Disposed	2026-03-01	Common Stock (9000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.48 to $94.537. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.25 to $94.62. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period